rs10497953

Variant summary

Our verdict is . The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005235.3(ERBB4):​c.421+19790A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0421 in 152,122 control chromosomes in the GnomAD database, including 158 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.042 ( 158 hom., cov: 32)

Consequence

ERBB4
NM_005235.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0290

Publications

4 publications found
Variant links:
Genes affected
ERBB4 (HGNC:3432): (erb-b2 receptor tyrosine kinase 4) This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
ERBB4 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 19
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005235.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0639 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005235.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERBB4
NM_005235.3
MANE Select
c.421+19790A>G
intron
N/ANP_005226.1Q15303-1
ERBB4
NM_001439005.1
c.421+19790A>G
intron
N/ANP_001425934.1
ERBB4
NM_001042599.2
c.421+19790A>G
intron
N/ANP_001036064.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERBB4
ENST00000342788.9
TSL:1 MANE Select
c.421+19790A>G
intron
N/AENSP00000342235.4Q15303-1
ERBB4
ENST00000436443.5
TSL:1
c.421+19790A>G
intron
N/AENSP00000403204.1Q15303-3
ERBB4
ENST00000484594.5
TSL:1
n.473+19790A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0421
AC:
6406
AN:
152008
Hom.:
157
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0661
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0192
Gnomad ASJ
AF:
0.0545
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0549
Gnomad FIN
AF:
0.0174
Gnomad MID
AF:
0.0605
Gnomad NFE
AF:
0.0385
Gnomad OTH
AF:
0.0478
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0421
AC:
6407
AN:
152122
Hom.:
158
Cov.:
32
AF XY:
0.0410
AC XY:
3050
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0660
AC:
2741
AN:
41534
American (AMR)
AF:
0.0191
AC:
292
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.0545
AC:
189
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.0550
AC:
265
AN:
4820
European-Finnish (FIN)
AF:
0.0174
AC:
184
AN:
10564
Middle Eastern (MID)
AF:
0.0582
AC:
17
AN:
292
European-Non Finnish (NFE)
AF:
0.0385
AC:
2619
AN:
67988
Other (OTH)
AF:
0.0469
AC:
99
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
314
628
942
1256
1570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0419
Hom.:
150
Bravo
AF:
0.0428
Asia WGS
AF:
0.0230
AC:
79
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
1.7
DANN
Benign
0.70
PhyloP100
-0.029
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.